Graefes Arch Clin Exp Ophthalmol (2017) 255:1863–1864 DOI 10.1007/s00417-017-3730-x LETTER TO THE EDITOR Encouraging results of 25G+ minimally invasive vitrectomy surgery for diabetic tractional retinal detachment Koushik Tripathy Received: 9 February 2017 /Accepted: 20 June 2017 /Published online: 30 June 2017 Springer-Verlag GmbH Germany 2017 Keywords Proliferative diabetic retinopathy Tractional minimally invasive vitrectomy surgery (MIVS) is in- . . retinoschisis Pars plana vitrectomy Diabetic vitrectomy creasingly becoming the choice for vitreoretinal sur- geons for diabetic vitrectomy, even in advanced com- bined rhegmatogenous-tractional retinal detachment Dear Editor, (RTRD) cases. Other advantages of MIVS include better fluidics, maintained intraocular pressure during 1. I read with interest the article reporting encouraging surgery, better cosmesis, decreased or absent need of results of 25G+ pars plana vitrectomy (PPV) in dia- suturing of sclerotomy sites, and no clinically signif- betic tractional retinal detachment (TRD) by Mikhail icant increase in duration of surgery . The encour- and colleagues .Ihumblywanttodiscuss afew aging results of initial retinal reattachment of 91% and points. During combined cataract surgery with PPV, final anatomical reattachment of 98%  reflect the Mikhail and colleagues make the pars plana ports af- efficacy of diabetic vitrectomy using MIVS. Only six ter the cataract surgery is
Graefe's Archive for Clinical and Experimental Ophthalmology – Springer Journals
Published: Jun 30, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera